Literature DB >> 21451450

Central neck dissection for papillary thyroid cancer.

David T Hughes1, Gerard M Doherty.   

Abstract

BACKGROUND: Central compartment lymph node dissection is a common adjunct to thyroidectomy in the treatment of papillary thyroid cancer. The indications, surgical technique, potential benefits, and operative risks of this procedure should be clearly defined in order to provide optimal care to these patients.
METHODS: A systematic review of the literature and an analysis of evidence-based recommendations were performed regarding central neck node dissection for patients with papillary thyroid carcinoma.
RESULTS: Cervical nodal metastasis in papillary thyroid cancer is a common occurrence. The presence of metastasis is associated with increased recurrence rates and may decrease survival. Detection of central and lateral neck nodal metastasis preoperatively with clinical examination and cervical ultrasound is important in determining the appropriate initial surgical management. Level VI neck dissection and central neck dissection are terms often used interchangeably to describe surgical excision of all lymph nodes from the hyoid bone to the sternal notch between the carotid arteries, but the addition of the superior mediastinal lymph nodes in compartment VII should be included in the central neck dissection. Due to improved recurrence rates and survival, therapeutic central neck dissection is recommended for all patients with nodal involvement detected pre- or intraoperatively. Prophylactic central neck dissection in patients without detectable nodal disease remains a controversial topic due to a lack of definitive evidence of improved recurrence rates or survival and the possibility of higher complication rates compared to total thyroidectomy alone. Reoperative central nodal dissection can be a challenging procedure with increased complication rates but with good outcomes in experienced centers.
CONCLUSIONS: Central neck lymph node dissection plays an important role in the appropriate treatment of papillary thyroid cancer at initial presentation and in cases of recurrent disease. Surgeons caring for this group of patients should have familiarity and skill with this procedure.

Entities:  

Mesh:

Year:  2011        PMID: 21451450     DOI: 10.1177/107327481101800202

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  24 in total

1.  Thymectomy in central lymph node dissection for papillary thyroid cancer.

Authors:  Du-Ping Huang; Xiao-He Ye; You-Qun Xiang; Xiao-Hua Zhang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.

Authors:  Parameswaran Rajeev; Sohail Ahmed; Tarek M Ezzat; Gregory P Sadler; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2012-12-30       Impact factor: 3.445

Review 3.  The association between BRAF (V600E) mutation and pathological features in PTC.

Authors:  Xin Liu; Kangkang Yan; Xuejun Lin; Longyu Zhao; Wenxiu An; Chunpeng Wang; Xiaodong Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-04       Impact factor: 2.503

Review 4.  New developments in the diagnosis and treatment of thyroid cancer.

Authors:  David F Schneider; Herbert Chen
Journal:  CA Cancer J Clin       Date:  2013-06-24       Impact factor: 508.702

5.  Pattern of nodal involvement in papillary thyroid cancer: a challenge of quantitative analysis.

Authors:  Fausto Fama; Marco Cicciù; Giuseppe Lo Giudice; Alessandro Sindoni; Jessica Palella; Arnaud Piquard; Olivier Saint-Marc; Salvatore Benvenga; Ennio Bramanti; Gabriele Cervino; Maria Gioffre Florio
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma.

Authors:  Dana M Hartl; Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Martin Schlumberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

7.  A mathematical model using computed tomography for the diagnosis of metastatic central compartment lymph nodes in papillary thyroid carcinoma.

Authors:  Tianrun Liu; Xuan Su; Weichao Chen; Lie Zheng; Li Li; AnKui Yang
Journal:  Eur Radiol       Date:  2014-08-09       Impact factor: 5.315

8.  Impact of lymph node ratio on survival in papillary thyroid cancer.

Authors:  David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2012-12-23       Impact factor: 5.344

9.  Impact of lymph node metastases identified on central neck dissection (CND) on the recurrence of papillary thyroid cancer: potential role of BRAFV600E mutation in defining CND.

Authors:  Ali S Alzahrani; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2013-01-21       Impact factor: 5.678

10.  Anatomic Variability of the Upper Mediastinal Lymph Node Level VII.

Authors:  Dana M Hartl; Ingrid Breuskin; Haïtham Mirghani; Amandine Berdelou; Désirée Déandréis; Edwige Pottier; Isabelle Borget; Martin Schlumberger; Sophie Leboulleux
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.